rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

AdvanSix Inc.

ASIX · NYSE

MaterialsChemicalsNot moving yet

ASIX stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 12 weeks. It is 18.9% below that average now. Chemicals: 24% of its 85 stocks in an uptrend (−5 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 12
Industry in uptrend
24% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
5
Institutions holding
238 (-8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct
18%38%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has been slipping. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$303K$0$132KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

5 disclosed lines: House 1, Senate 4, executive 0; 3 people.

WhoDidAmountTraded
Thomas R. Carper Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k8 Nov 2016filed 1 Dec 2016
Richard L. Hanna House: U.S. House ClerkNY22exchanged$1k–$15k7 Oct 2016filed 27 Nov 2016
Sheldon Whitehouse Senate: U.S. Senate eFDSenatorexchangeddependent child$1k–$15k3 Oct 2016filed 7 Nov 2016
Sheldon Whitehouse Senate: U.S. Senate eFDSenatorexchangedjoint$1k–$15k3 Oct 2016filed 7 Nov 2016
Sheldon Whitehouse Senate: U.S. Senate eFDSenatorexchanged$1k–$15k3 Oct 2016filed 7 Nov 2016

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders238-8 on the quarter
New · exited28 · 37
Reported value$484.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20262,440,480$48.5M+156,545+6.9%
CastleKnight Management LPadded · filed 14 Aug 20261,590,318$31.6M+958,537+151.7%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,407,349$28.0M+96,343+7.3%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 20261,363,346$27.1M+236,709+21.0%
AEGIS FINANCIAL CORPunchanged · filed 12 Aug 20261,209,629$24.0M00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,151,355$22.9M+27,898+2.5%
ALLIANCEBERNSTEIN L.P.reduced · filed 14 Aug 2026863,897$21.1M-7,079−0.8%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026700,057$13.9M+61,486+9.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026692,516$13.8M+40,268+6.2%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPreduced · filed 13 Aug 2026664,944$13.2M-63,348−8.7%
31 Mar 2023 – 30 Jun 2026
235246257Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Patrick Williams Company insiderDirector · last 6 Oct 20260 · 0
Dana C. O'Brien Company insiderDirector · last 22 Jun 20260 · 0
Daryl Roberts Company insiderDirector · last 22 Jun 20260 · 0
Donald P. Newman Company insiderDirector · last 22 Jun 20261 · 0
Gena C. Lovett Company insiderDirector · last 22 Jun 20260 · 0
Jeffrey J. Bird Company insiderDirector · last 22 Jun 20260 · 0
Sharon Spurlin Company insiderDirector · last 22 Jun 20263 · 0
Todd D. Karran Company insiderDirector · last 22 Jun 20261 · 0
Patrick C. Day Company insiderSVP, CFO · last 27 Apr 20260 · 0
Rachael E. Ryan Company insiderVP, Controller · last 24 Mar 20260 · 0
Achilles B. Kintiroglou Company insiderSVP, General Counsel · last 28 Feb 20260 · 24
Christopher Gramm Company insiderVP and Interim CFO · last 28 Feb 20260 · 29

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+15%
MEOH MethanexLeading+12%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202510.8%
Free cash flow marginFY 2025 · to 31 Dec 20250.4%
Cash conversionFY 2025 · to 31 Dec 2025249%
Research spendFY 2025 · to 31 Dec 20250.6%
Share count trendFY 2025 · to 30 Jan 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$19.8M
Free cash flowFY 2025 · to 31 Dec 2025$6.4M

Analyst forecasts

No analyst forecasts yet.